A Study to Assess the Safety, Tolerability and Efficacy of ION775
- Status
- RECRUITING
- Phase
- PHASE2
Clinical Trials Related to Severe Hypertriglyceridemia
Related studies linked through entity extraction aliases.
A Study of Solbinsiran (LY3561774) in Participants With Severe Hypertriglyceridemia
- Status
- RECRUITING
- Phase
- PHASE2
Study of Plozasiran in Adults With Severe Hypertriglyceridemia at Risk of Acute Pancreatitis
- Status
- RECRUITING
- Phase
- PHASE3
A Phase II Study to Evaluate the Efficacy and Safety of of DR10624 in Subjects With Severe Hypertriglyceridemia
- Status
- COMPLETED
- Phase
- PHASE2
Study of Plozasiran in Adults With Severe Hypertriglyceridemia
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE3
Study of Plozasiran (ARO-APOC3) in Adults With Severe Hypertriglyceridemia
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE3
To Evaluate the Efficacy and Safety of Pegozafermin in Subjects With Severe Hypertriglyceridemia
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE3
CORE-OLE: A Study of Olezarsen (ISIS 678354) Administered Subcutaneously to Participants With Severe Hypertriglyceridemia (SHTG)
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE3
A Study of Olezarsen Administered Subcutaneously to Participants With Severe Hypertriglyceridemia
- Status
- COMPLETED
- Phase
- PHASE3
A Study of Olezarsen (Formerly Known as AKCEA-APOCIII-LRx) in Adults With Hypertriglyceridemia and Atherosclerotic Cardiovascular Disease (Established or at Increased Risk for), and/or With Severe Hypertriglyceridemia
- Status
- COMPLETED
- Phase
- PHASE2
A Study of Olezarsen (ISIS 678354) Administered to Participants With Severe Hypertriglyceridemia
- Status
- COMPLETED
- Phase
- PHASE3
Study to Evaluate ARO-APOC3 in Adults With Severe Hypertriglyceridemia
- Status
- COMPLETED
- Phase
- PHASE2
Safety and Efficacy of MAT9001(Omega-3-pentaenoic Acid) in Subjects With Triglycerides ≥500 mg/dL and <2000 mg/dL
- Status
- WITHDRAWN
- Phase
- PHASE3
Study to Explore the Efficacy and Safety of BIO89-100 (Pegozafermin) in Participants With Severe Hypertriglyceridemia
- Status
- COMPLETED
- Phase
- PHASE2
Study to Evaluate the Efficacy and Safety of K-877 in Adult Patients With Fasting High Triglyceride Levels and Mild or Moderate Renal Impairment
- Status
- COMPLETED
- Phase
- PHASE3
Study to Evaluate the Efficacy and Safety of K-877 in Adult Patients With Fasting High Triglyceride Levels and Normal Renal Function
- Status
- COMPLETED
- Phase
- PHASE3
A 12-Week Study to Assess the Efficacy Safety and Tolerability of Gemcabene in Subjects With Severe Hypertriglyceridemia
- Status
- COMPLETED
- Phase
- PHASE2
An Open-Label Crossover Study to Compare the Relative Bioavailability, Efficacy and Safety of Epanova® and Lovaza® in Men and Women With a History of Pancreatitis
- Status
- COMPLETED
- Phase
- PHASE1
The Efficacy of EPA+DHA (SC401B) for Lowering Triglyceride Levels (≥ 500 mg/dL)
- Status
- WITHDRAWN
- Phase
- PHASE3
Epanova® for Lowering Very High Triglycerides
- Status
- COMPLETED
- Phase
- PHASE2/PHASE3